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Abstract. Chronic pulmonary infections are the principal cause of morbidity and mortality in 
individuals with cystic fibrosis (CF). Due to the polymicrobial nature of these infections, the 
identification of the particular bacterial species responsible is an essential step in diagnosis and 
treatment. Current diagnostic procedures are time-consuming, and can also be expensive, 
invasive and unpleasant in the absence of spontaneously expectorated sputum. The 
development of a rapid, non-invasive methodology capable of diagnosing and monitoring 
early bacterial infection is desired. Future visions of real-time, in situ diagnosis via exhaled 
breath testing rely on the differentiation of bacteria based on their volatile metabolites. The 
objective of this proof-of-concept  study was to investigate whether a range of CF-associated 
bacterial species  (i.e. Pseudomonas aeruginosa, Burkholderia cenocepacia, Haemophilus 
influenzae, Stenotrophomonas maltophilia, Streptococcus pneumoniae and Streptococcus 
milleri) could be differentiated based on their in vitro volatile metabolomic profiles. 
Headspace samples were collected using solid phase microextraction (SPME), analyzed using 
comprehensive two-dimensional gas chromatography – time-of-flight mass spectrometry 
(GC×GC-TOFMS) and evaluated using principal component analysis (PCA) in order to assess 
the multivariate structure of the data. Although it was not possible to effectively differentiate 
all six bacteria using this method, the results revealed that the presence of a particular pattern 
of VOCs (rather than a single VOC biomarker) is necessary for bacterial species identification. 
The particular pattern of VOCs was found to be dependent upon the bacterial growth phase 
(e.g. logarithmic vs. stationary) and sample storage conditions (e.g. short-term vs. long-term 
storage at -18 °C). Future studies of CF-associated bacteria and exhaled breath condensate will 
benefit from the approaches presented in this study and further facilitate the production of 
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1. Introduction 
 Cystic fibrosis (CF) is the most common lethal inherited disorder in the Caucasian 
population [1]. It is characterized by the accumulation of excessively thick, sticky mucus that blocks 
the airways and is associated with the increased prevalence of certain pathogenic bacteria. Persistent 
bacterial colonization in the lungs precedes recurrent pulmonary infections causing inflammation and 
irreversible lung damage, which often leads to respiratory failure and death. Some studies have 
suggested that early, aggressive antibiotic therapy may increase the chances of preventing or delaying 
chronic bacterial colonization [2–5]. Early detection of established colonization with pathogenic 
bacteria (such as Pseudomonas aeruginosa) is critical for CF patients because chronic respiratory 
infections are difficult to eradicate from CF-infected airways once acquired. 
 The detection of CF lung infections generally relies on culturing of pathogenic 
microbiological organisms from lower airway secretions [6]. As expectorated samples can be difficult 
to obtain in patients with negligible sputum production, particularly in children, alternative methods 
such as sputum induction [7] or bronchoalveolar lavage [8] are often required. These procedures are 
time-consuming, expensive, invasive and unpleasant, especially for young children and infants.  
 CF lungs can be colonized and infected by many different bacterial species (e.g. Haemophilus 
influenzae, Burkholderia cepacia complex, Pseudomonas aeruginosa, etc.) [1]. Identification of the 
specific pathogen allows for targeted antibiotic therapy, which reduces the likelihood for the 
development of antibiotic resistance, and improves bacterial eradication and clinical response [6]. The 
correct culture conditions are vital for bacterial identification [2], and may require several different 
selective growth media and several days for identification and antibiotic susceptibility testing. 
 For these reasons, a rapid non-invasive diagnostic technique to monitor bacterial infection in 
CF patients is highly desirable. Current focus in the literature is aimed at developing techniques for 
exhaled breath analysis [9–13]. Future visions involve real-time analysis of exhaled breath 
(e.g. bedside diagnosis using an electronic nose) [14–16], which could provide clinicians with 
immediate information, facilitating rapid diagnosis and treatment, in addition to therapeutic 
monitoring. The non-invasive nature of exhaled breath testing is also appealing for pediatric patients 
that may have difficulty producing sputum samples for microbiological culturing. However, before 
these objectives can be met, the first step in the development of an exhaled breath test for the 
diagnosis of respiratory infections is the identification of volatile organic compounds (VOCs) that: 
1) can be used as suitable pathogen-specific biomarkers [17,18];  and 2) may reflect alterations in 
growth characteristics in important bacterial populations. 
 A number of different analytical techniques have been reported throughout the literature for 
the detection and identification of VOCs produced by in vitro cultures of CF pathogens including: 
selected ion flow tube mass spectrometry (SIFT-MS) [17,19], proton transfer reaction mass 
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spectrometry (GC-MS) [18,24,25] and more recently comprehensive two-dimensional gas 
chromatography – time-of-flight mass spectrometry (GC×GC-TOFMS) [26,27]. Although GC-MS is 
typically considered the gold standard amongst analytical methods in this field [18], it often suffers 
from insufficient peak capacity, limited sensitivity and restricted selectivity; this makes co-eluting 
peaks, chromatographic artefacts and dynamic range difficult to manage [28]. Multidimensional 
techniques, such as GC×GC-TOFMS, offer distinct advantages when faced with complex matrices 
that exhibit these issues. The benefits of GC×GC have been highlighted in many fields including: 
petroleum products [29,30], food and flavour [31,32], environmental studies [33], forensic science 
[28,34,35] and metabolomics [36,37]. In the first reported application of GC×GC-TOFMS for in vitro 
bacterial headspace characterization, Bean et al. identified 28 new VOCs that had not been previously 
reported for Pseudomonas aeruginosa [26]. This nearly doubled the list of previously published 
volatile metabolites for one of the most prevalent bacterial species associated with CF lung infections, 
demonstrating the wealth of information that can be gained by using GC×GC-TOFMS.  
 Many of the microbial species that can produce pulmonary infections in CF patients 
experience similar metabolic pathways; therefore, the challenge is determining whether CF-associated 
bacterial species can, in fact, be discriminated by their volatile metabolites [18]. Previous studies have 
attempted to identify species-specific volatile biomarkers for CF-associated pathogens; however, the 
number of bacterial species studied is often limited (e.g. n = 2) [24,25]. The principal objective of this 
proof-of-concept study was to investigate whether a range of bacterial species (n = 6) could be 
differentiated based on their volatile metabolomic profiles collected using headspace solid phase 
microextraction (HS-SPME) and analyzed by GC×GC-TOFMS. GC×GC-TOFMS was employed in 
order to expand the VOC profile available for characterization. The bacterial species investigated 
were chosen based on their association with CF lung infections [1,38–40]. The species examined 
included: Pseudomonas aeruginosa, Burkholderia cenocepacia, Haemophilus influenzae, 
Stenotrophomonas maltophilia, Streptococcus pneumoniae and Streptococcus milleri. Because access 
to analytical instrumentation may be limited and samples often need to be stored prior to analysis, a 
secondary aim of this study was to investigate whether the volatile metabolomic profiles of the 
bacteria changed over time. To do this bacterial headspace samples were collected and analyzed after 
both short-term (i.e. 2 – 5 days) and long-term (i.e. 48 – 50 days) storage at -18 °C. Each bacterial 
species was also cultured under two distinct growth phase conditions (i.e. logarithmic and stationary) 
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2. Materials and Methods 
2.1.  Bacterial Culturing 
 The bacterial isolates were stored at -80 °C in Luria broth, Lennox (LB-Lennox; 10 g 
tryptone, 5 g yeast extract, 5 g NaCl) with 10 – 15% glycerol. H. influenzae was subcultured onto 
chocolate agar plates while all other isolates were subcultured onto blood agar (Oxoid Blood Agar 
base No. 2, Basingstoke, Hampshire, England) containing 5% defibrinated horse blood. The agar 
plates were incubated aerobically at 37 °C overnight. S. pneumoniae and H. influenzae plates were 
incubated overnight at 37 °C with 5% CO2. Single colonies were taken from fresh culture plates 
grown overnight and inoculated into 5 mL of LB-Lennox or Brain Heart Infusion (BHI) broth inside 
sterilized 20 mL headspace vials, which were sealed airtight with a screw cap containing a 1.3 mm 
thick polytetrafluoroethylene/silicone septum (Sigma-Aldrich, Castle Hill, NSW, Australia). 
S. pneumoniae and H. influenzae were cultured in BHI broth while all other bacteria were grown in 
LB-Lennox. All strains were cultured at 37 °C with vigorous shaking (200 rpm) for 16 h in order to 
advance the development of samples of each bacterial species to the stationary phase of growth. After 
16 h of growth, bacterial cultures were cooled on ice. To obtain samples of each bacterial species in 
the logarithmic phase of growth, freshly grown cultures (prepared overnight as described above) were 
inoculated as 1:100 dilutions in 5 mL of LB-Lennox or BHI broth inside sterilized 20 mL headspace 
vials sealed airtight. All strains were then cultured at 37 °C for 5 h with vigorous shaking 
(approximately 220 rpm) before being cooled on ice. Following bacterial culturing, which was 
performed off-site, the samples were transported on ice to the laboratory where they were stored 
at -18°C prior to analysis.  
 Each bacterial species was prepared in quadruplicate during both logarithmic and stationary 
phases of growth. Two of the bacteria samples were stored for 2 – 5 days at -18 °C prior to HS-SPME 
VOC collection and GC×GC-TOFMS analysis (i.e. short-term storage), while the other two samples 
were stored for 48 – 50 days at -18 °C (i.e. long-term storage) prior to analysis, therefore resulting in 
duplicate bacteria samples per overall treatment. Duplicate samples of LB-Lennox and BHI broth 
controls (i.e. broth only) were also prepared under both logarithmic and stationary growth phase 
conditions for the purpose of determining background VOCs associated with the growth media. 
Similar to the bacteria samples, half of the LB-Lennox and BHI broth control samples were stored 
under short-term storage conditions while the other half were stored under long-term storage 
conditions; this resulted in one replicate LB-Lennox control and one replicate BHI broth control per 
overall treatment.  
 
2.2. HS-SPME VOC Collection 
 VOC collection was carried out via a previously optimized headspace sampling method 
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(DVB/CAR/PDMS) 24 Ga Stableflex SPME fibre and manual fibre holder (Supelco, Bellefonte, PA, 
USA). The fibre was initially conditioned for 60 min at 270 °C before first use, according to the 
manufacturer’s recommendations. Fibre reconditioning (5 min at 250 °C) was performed as necessary. 
A fibre blank was completed before sampling and after every 4 sample injections using the GC×GC-
TOFMS method described below.  
 Prior to VOC collection, the SPME fibre was pre-loaded with an internal standard. This was 
performed by exposing the SPME fibre to the headspace of 200 µL of a 100 ppm solution of 
bromobenzene (GC grade, Sigma-Aldrich), prepared in methanol (HPLC grade, Sigma-Aldrich) 
inside a sealed headspace vial, for 15 s at room temperature. The pre-loading of an internal standard 
onto a SPME fibre has previously been demonstrated to exhibit good reproducibility for volatile and 
semivolatile internal standard analytes [41]. Using this approach the internal standard vial may be 
reused for numerous analyses without exhibiting significant loss [41]. This technique has been 
previously optimized in our laboratory to provide a relative standard deviation of <15% in the internal 
standard peak area. In this study, the intraday precision ranged from 4.2 – 14.7%, with an interday 
precision of 12.2% for the overall trial. 
 The HS-SPME sampling method (adapted from Bean et al. [26]) included sample thawing, 
sample incubation and sample headspace extraction. Sample thawing was performed at 4 °C 
overnight. Prior to headspace extraction, the sample was incubated for 10 min at 50 °C in a dry bath 
heating block (Thermoline Scientific, Wetherill Park, NSW, Australia). Sample extraction was 
achieved by exposing the SPME fibre to the sample headspace for 10 min while the sample was 
maintained at 50 °C. The SPME fibre was thermally desorbed in the GC×GC inlet for 5 min at 
250 °C. 
 
2.3. GC×GC-TOFMS Analysis 
 Sample analysis was conducted on a Pegasus® 4D GC×GC-TOFMS system (LECO, Castle 
Hill, NSW, Australia) equipped with a liquid nitrogen cryogenic quad jet modulator. The column 
configuration consisted of a 30 m × 0.250 mm inner diameter (ID), 1.40 µm film thickness Rxi®-
624Sil MS column (Restek Corporation, Bellefonte, PA, USA) in the first dimension (1D) and a 2 m × 
0.250 mm ID, 0.50 µm film thickness Stabilwax® column (Restek Corporation) in the second 
dimension (2D). The 1D and 2D columns were connected by a SilTite™ µ-Union (SGE Analytical 
Science, Wetherill Park, NSW, Australia).  
 The speed optimized flow [42] and optimal heating rate [43] were calculated in order to 
obtain optimal resolution in the 1D. High purity helium (BOC, Sydney, NSW, Australia) was used as 
the carrier gas with a constant flow rate of 2.0 mL/min. Sample introduction was performed using 
splitless injection with a 30 s purge time. The primary oven was programmed to begin at 40 °C (held 
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primary oven, the secondary oven was programmed to have a constant offset of +5 °C and the 
modulator a constant offset of +30 °C. A modulation period of 4 s was used with a 0.4 s hot pulse and 
1.6 s cooling time between stages. Mass spectra were collected from m/z 25 – 500 at a rate of 200 Hz 
with an acquisition delay of 120 s. A 200 V offset above the optimized detector voltage was used, the 
electron ionization energy was set at 70 eV and the ion source and MS transfer line were maintained 
at 200 °C and 250 °C, respectively. 
 
2.4. Data Processing 
 ChromaTOF® (version 4.51.6.0; LECO) was used for data processing. The baseline was 
automatically smoothed by the software with an 80% offset. The 1D peak width was set at 20 s while 
the 2D peak width was set at 0.1 s. The minimum signal-to-noise ratio (S/N) for the base peak and sub-
peaks was set at 250 and 20, respectively. A minimum similarity match >800 to the 2011 National 
Institute of Standards and Technology (NIST) mass spectral library database was used for initial 
identification.  
 Peak identifications were supported with the use of 1D retention indices and retention time 
matching with chemical standards when possible using a standard test mixture containing a range of 
compounds covering several different compound classes (complete list of standards documented in 
Perrault et al. [44]). The 1D retention indices were calculated using the n-alkanes within the standard 
test mixture and a Retention Index Method created in ChromaTOF®. For analysis of the standards, the 
SPME fibre was exposed to 1 µL of a 100 ppm solution of the test mixture, prepared in carbon 
disulfide (≥99% anhydrous, Sigma-Aldrich) inside a sealed headspace vial, for 10 min at 50 °C in a 
dry bath heating block. The SPME fibre was then desorbed for analysis as previously described.  
 The Statistical Compare software feature in ChromaTOF® was used for peak alignment. 
Samples were input into Statistical Compare and two approaches were taken to facilitate visualization 
by multivariate analysis. In the first approach (denoted approach A), the samples were processed in 
two separate files based on growth phase; within each of these files seven classes were created that 
included the control samples (i.e. media) as a single class (n = 4 samples) and one class for each 
individual bacterial species (n = 6 classes with n = 4 samples within each class). For approach A, 
analytes were only retained if found in 75% of the samples within a class. This approach was used to 
investigate the primary objective of the paper (i.e. to determine whether the six bacterial species could 
be differentiated based on their volatile metabolomic profiles). In a second approach (denoted 
approach B), the samples were input into a single file and separated into two classes: control (n = 8 
samples) and bacteria (n = 48 samples). For approach B, analytes were only retained if found in 24 
samples out of the 56 total samples or if found in 50% of the samples within a class. This approach 
was applied to see if any further information could be extracted from the data with the use of a two-




  Page 7 
 For both approaches, the following settings applied. A S/N of 20 was used to search for peaks 
not found during the initial peak finding step. A mass spectral match >600 was required for peaks to 
be identified as the same compound across chromatograms during alignment. When analytes did not 
meet this mass spectral match threshold during alignment they were removed from the final 
compound list. To allow for retention time deviations between samples the maximum retention time 
differences specified in the 1D and 2D were 4 s (i.e. 1 modulation period) and 0.6 s, respectively. After 
alignment, the analyte peak areas (calculated using unique mass) were normalized using the 
bromobenzene internal standard peak area. A Fisher ratio (i.e. the ratio of between-class variance to 
within-class variance) was also calculated for each analyte using the Statistical Compare software 
feature. In the case where an analyte was absent from a class or only detected in a single sample in a 
class, the within-class variance could not be calculated (or was equal to 0) and a value of undefined 
was given for the Fisher ratio. Analytes with higher Fisher ratio values (or those labelled as 
“undefined”) indicated compounds that statistically differed in abundance between the defined 
classes.  
 Fisher ratio filtering was performed based on its success in previous applications for 
identifying class-distinguishing compounds [45–49]. Compounds with Fisher ratios above the critical 
value (Fcrit = 2.57 and 4.02 for approaches A and B, respectively), which includes those labelled as 
“undefined”, were exported as a *.csv file and imported into Microsoft Excel for the manual removal 
of chromatographic artefacts (i.e. column bleed and phthalates). The F-distribution was used to 
calculate Fcrit for each aligned Statistical Compare compound list. The Fcrit value is computed based 
on three approach-dependent criteria: the number of classes in the analysis, the degrees of freedom for 
each class and the significance level chosen ( = 0.05). Principal component analysis (PCA) was 
carried out in The Unscrambler® X (version 10.3; CAMO Software, Oslo, Norway). Data pre-
processing steps performed in The Unscrambler® X prior to PCA included mean centring, variance 
scaling and unit vector normalization. These pre-treatment steps have been previously demonstrated 
for multivariate VOC analyses [50,51]. Following PCA, each dataset was evaluated for outlying 
samples by means of the Hotelling’s T2 95% confidence limit. All data were verified to contain no 
outliers. 
 
3. Results and Discussion 
3.1. HS-SPME-GC×GC-TOFMS Results 
 During this study, headspace samples were collected from six different CF-associated 
bacterial species and two different growth media (i.e. controls) using HS-SPME and analyzed using 
GC×GC-TOFMS. Figure 1 displays GC×GC-TOFMS total ion current (TIC) contour plots of the BHI 
control broth and the two bacterial species cultured in BHI broth: H. influenzae and S. pneumoniae. 
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in LB-Lennox (i.e. P. aeruginosa, B. cenocepacia, S. maltophilia and S. milleri) are displayed in 
figure 2. A scale of 0 – 40% of the normalized signal intensity was used in figure 1 and figure 2 in 
order to assist with chromatographic visualization of trace components, as a result of the wide 
dynamic range detected. The contour plots displayed in figure 1 and figure 2 illustrate that 
chromatographic differences can be observed between: 1) the individual bacterial species; and 2) 
between the bacterial samples and the respective control samples.  
 With a TIC S/N greater than 250, an average of 397 peaks were detected in the control 
samples compared to an average of 472 peaks detected in the bacterial samples. This represents an 
order-of-magnitude increase in the number of VOCs detected using GC×GC-TOFMS when compared 
to the volatile profiles of CF-associated bacterial species obtained in vitro using traditional one-
dimensional GC-MS [18,24,25]. This is a direct result of the increased peak capacity, sensitivity and 
selectivity afforded by GC×GC-TOFMS. These benefits allowed co-eluting peaks, chromatographic 
artefacts and dynamic range to be more easily managed in this study, leading to an overall increase in 
peak detectability. This resulted in a more comprehensive volatile metabolomic profile of each 
sample, with each individual VOC having a higher likelihood of being detected and quantified 
accurately. Compounds detected before filtering included acids, alcohols, aldehydes, aliphatic 
hydrocarbons (i.e. alkanes, alkenes and alkynes), aromatic hydrocarbons, esters, ethers, functionalized 
benzenes (i.e. benzene ring with various N, O, or S heteroatomic functional groups), heteroaromatics 
(i.e. aromatic ring containing a N, O, or S heteroatom), ketones, sulfur-containing compounds, 
nitrogen-containing compounds, chromatographic artefacts (e.g. siloxanes, silanols, silanes and 
phthalates) and “other” compounds containing multiple functional groups. A similar range of chemical 
classes has previously been reported in the in vitro headspace analysis of P. aeruginosa by HS-SPME-
GC×GC-TOFMS [26]. Overall, the use of GC×GC-TOFMS in this study highlights the wealth of 
additional information that can be gained from this technique for volatile metabolomic profiling and 
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Figure 1. GC×GC-TOFMS TIC contour plots of a) BHI control broth and those bacterial species cultured in 
BHI broth under stationary growth phase conditions and analyzed after short-term storage: b) H. influenzae and 
c) S. pneumoniae.  
 
 
Figure 2. GC×GC-TOFMS TIC contour plots of a) LB-Lennox control broth and those bacterial species 
cultured in LB-Lennox under stationary growth phase conditions and analyzed after short-term storage: 
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3.2. Bacterial Differentiation 
 In order to determine whether the six bacterial species could be differentiated based on their 
volatile metabolomic profiles, the chromatographic results were evaluated using principal component 
analysis (PCA). This allowed visualization of the multivariate structure of the data based on the 
volatile metabolomic profile as opposed to a univariate approach based on individual compounds. In 
order to examine the structure of the data related to bacterial differentiation, two separate PCA 
analyses were conducted whereby samples prepared under logarithmic and stationary growth phase 
conditions were evaluated as two separate datasets. Within each dataset the samples were separated 
into seven classes (i.e. six individual bacterial classes and one control class) for alignment and Fisher 
ratio filtering.  
 Using this method (designated as Statistical Compare approach A), analytes were only 
retained if found in 75% of the samples within a class, where the number of samples in each class was 
equal to four (i.e. two short-term storage samples and two long-term storage samples). This filtering 
method allowed for the identification of analytes that were detected in both short-term and long-term 
storage samples for a particular bacteria or control, which is important for laboratories that may need 
to store samples prior to analysis while waiting for analytical instrumentation to become available. 
Using Statistical Compare approach A, 324 compounds were retained after alignment for the samples 
cultured under logarithmic growth phase conditions. Of the 324 compounds, 38 analytes were 
identified that met all post-processing criteria (i.e. found to have a Fisher ratio above the 
Fcrit threshold of 2.57, sufficient spectral matching and not related to chromatographic artefacts). 
Hereafter the term “detected compounds” refers to the compounds that met these criteria and were 
used for PCA analysis. Similarly, for samples cultured under stationary growth phase conditions, 334 
compounds were initially retained after alignment using Statistical Compare approach A. After post-
processing procedures, 76 detected compounds remained that were used for PCA analysis. 
 The additional information gained through the use of GC×GC-TOFMS (compared to 
traditional GC-MS) in combination with complementary statistical software features allowed for the 
above described approach to be applied in order to select compounds of interest rather than relying on 
all compounds identified. The compounds of interest selected in this post-processing list should 
provide optimal discrimination when using PCA. 
 Figure 3 and figure 4 display the PCA scores and loadings plots produced for the detected 
compounds in both the logarithmic (figure 3(a) and figure 3(b), respectively) and stationary (figure 
4(a) and figure 4(b), respectively) growth phase analyses. Compound identifications corresponding to 
the numbers in the loadings plots can be found in Table S-1 (samples cultured under logarithmic 
growth phase conditions) and Table S-2 (samples cultured under stationary growth phase conditions) 
in the Supplementary Data. The explained variance observed for the principal component axes in 
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were originally higher before data transformations (i.e. mean centring, variance scaling and unit 
vector normalization) were performed; however, data transformations and filtering reduced the 
amount of noise introduced into the overall dataset and therefore by performing these steps the 
resulting axis loadings were reduced. This is not a negative point but rather increases the ability to 
differentiate the samples based on the structure of the data. In addition, the more principal 
components considered, the larger the amount of variation that is taken into account. For this reason 
PC-3 was also investigated but was not found to provide any further differentiation between the 
bacterial species under logarithmic or stationary growth phase conditions. 
 
 
Figure 3. Principal component analysis using pre-processed GC×GC-TOFMS peak area data for compounds 
detected in logarithmic growth phase samples with Statistical Compare approach A: a) scores plot; b) loadings 
plot (list of compounds available in Table S-1 in the Supplementary Data). Closed symbols represent samples 
analyzed after short-term storage and open symbols represent samples analyzed after long-term storage. 
PA = P. aeruginosa; BC = B. cenocepacia; HI = H. influenzae; SMa = S. maltophilia; SP = S. pneumoniae; 
SMi = S. milleri; LB = Luria broth, Lennox; and BHI = Brain Heart Infusion broth. 
 
 
Figure 4. Principal component analysis using pre-processed GC×GC-TOFMS peak area data for compounds 
detected in stationary growth phase samples with Statistical Compare approach A: a) scores plot; b) loadings 
plot (list of compounds available in Table S-2 in the Supplementary Data). Closed symbols represent samples 
analyzed after short-term storage and open symbols represent samples analyzed after long-term storage. 
PA = P. aeruginosa; BC = B. cenocepacia; HI = H. influenzae; SMa = S. maltophilia; SP = S. pneumoniae; 
SMi = S. milleri; LB = Luria broth, Lennox; and BHI = Brain Heart Infusion broth. 
 
 Similar to the chromatographic profiles of the bacteria samples in figure 1 and figure 2, PCA 
allowed the visualization of varying degrees of differentiation and similarity between the volatile 
metabolomic profiles of the bacteria investigated. P. aeruginosa and B. cenocepacia produced similar 
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conditions. Under logarithmic growth phase conditions (figure 3(a) and figure 3(b)), P. aeruginosa 
and B. cenocepacia exhibited comparable concentrations of 2,4-dimethyl-heptane (13), 2-nonanone 
(34), 2-methyl-3-isopropylpyrazine (31), 2-methyl-furan (4), 1-decene (32) and mercaptoacetone (9) 
based on the available compound identification information (bracketed numbers following the 
compound names refer to the compound identification numbers in the corresponding loadings plot). 
However, under stationary growth phase conditions (figure 4(a) and figure 4(b)), the similarities in 
these bacterial species was attributed to a broader spectrum of compounds. S. pneumoniae and 
S. milleri also produced similar metabolic by-products to each other during both growth phases 
investigated. Under logarithmic conditions (figure 3(a) and figure 3(b)), S. pneumoniae and S. milleri 
exhibited comparable concentrations of acetic acid butyl ester (16) and 3-methyl-3-heptanol (22). 
Under stationary growth phase conditions (figure 4(a) and figure 4(b)), the similarities between S. 
pneumoniae and S. milleri were mainly attributed to the following VOCs: 1-ethylpropyl-benzene (67), 
3-methyl-butanal (16), 2-methyl-butanal (18), hexyl-benzene (69), 2,3-pentanedione (24) and 
α-methyl-benzeneacetaldehyde (63). During the logarithmic growth phase (figure 3(a) and figure 
3(b)), S. maltophilia generated a comparable VOC profile to two of the H. influenzae replicates with a 
similar concentration of L-leucine methyl ester (27); however, under stationary growth phase 
conditions (figure 4(a) and figure 4(b)), S. maltophilia produced similar VOCs (e.g. L-leucine methyl 
ester (57), 1-propanol (5), methyl thiolacetate (20), butyl 2-methylbutanoate (56), etc.) to 
P. aeruginosa and B. cenocepacia. H. influenzae produced a more variable VOC profile than the other 
bacteria under all conditions tested.  
 Under logarithmic growth phase conditions (figure 3(a)) the bacteria samples exhibited a 
higher degree of discrimination from the control samples in comparison with stationary growth phase 
conditions (figure 4(a)). There was also reduced variation between replicates for B. cenocepacia, S. 
pneumoniae and S. maltophilia under logarithmic growth phase conditions, which resulted in an 
increased overall discrimination between species.  
 Further investigation demonstrated that the variation observed within a single bacterial 
species (e.g. H. influenzae and S. maltophilia) was a result of the different storage conditions used 
(i.e. short-term vs. long-term storage). For example, the two H. influenzae replicates grouped on the 
left-side of the scores plot in figure 3(a) (closed symbols) were analyzed after short-term storage, 
while the two replicates grouped on the right-side of the plot (open symbols) were analyzed after 
long-term storage. Similar results were also found for the H. influenzae samples cultured under 
stationary growth phase conditions (figure 4(a)). 
 The two different growth media used herein (i.e. LB-Lennox and BHI broth) were selected for 
the optimal in vitro growth of the bacterial species investigated (i.e. LB-Lennox is poor for culturing 
S. pneumoniae and H. influenzae). It is of course expected that the use of different growth media may 
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analysis. Nevertheless, the use of two different growth media can be considered reflective of future in 
vivo samples (e.g. exhaled breath) where there is no media involved but there is a higher probability 
of biological variability (i.e. growth conditions) in the lung environment between patients. Despite the 
use of two different growth media, S. milleri (cultured using LB-Lennox) and S. pneumoniae (cultured 
using BHI broth), two bacteria belonging to the same genus, were still found to produce similar 
volatile metabolomic profiles as previously described. 
 When comparing all six of the CF-associated bacterial species it is apparent that the presence 
of a particular pattern of VOCs (rather than a single VOC biomarker) is necessary for bacterial 
species differentiation and identification. The particular pattern of VOCs also appears to be dependent 
upon the bacterial growth phase and sample storage conditions. Previous studies have claimed to 
identify species-specific biomarkers for CF-associated pathogens; however, the number of bacterial 
species studied is often limited (e.g. n = 2) [24,25]. Although it may be possible to effectively 
differentiate two or three bacterial species based on their respective VOC profiles 
(e.g. B. cenocepacia, S. maltophilia and S. pneumoniae in figure 3(a)), the results of this study 
highlight the importance of studying several different bacterial species with similar metabolic 
pathways when the objective is to identify species-specific biomarkers/VOC patterns. Increasing the 
number of replicates in the future and maintaining sample storage conditions, as discussed in the next 
section, may yield even greater differentiation between bacterial species. 
 
3.3. Storage Conditions 
 Statistical Compare was initially designed by LECO as an optional feature within 
ChromaTOF® to help manage large sets of metabolomics data allowing for analyte alignment and the 
calculation of descriptive statistics. For this reason, Statistical Compare appears to be well-suited for 
two-class models (e.g. cancerous vs. non-cancerous samples or diabetic vs. non-diabetic samples). In 
an attempt to conform to the design of Statistical Compare, the data was further analyzed using a two-
class model (i.e. bacteria vs. control), which is referred to throughout as Statistical Compare approach 
B. With this approach, more stringent filtering rules were applied during alignment in an effort to 
better characterize the difference in the volatile metabolomic profiles collected after short-term (i.e. 2 
– 5 days) vs. long-term (i.e. 48 – 50 days) storage at -18 °C. 
 The volatile metabolomic profiles acquired from the samples analyzed after long-term storage 
were clearly more complex as noted in both the GC×GC-TOFMS TIC contour plots (figure 5) and in 
the number of VOCs detected (e.g. an average increase of approximately 200 VOCs compared to 
samples analyzed after short-term storage). Similar results have also been reported for the analysis of 
volatiles from blood samples analyzed periodically over 5 weeks after storage at room temperature 
(25 °C), under refrigeration (4.5 °C) and in a freezer (-18 °C), with VOC profiles becoming more 
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profiles as a result of the different storage periods could be due to contamination, sample degradation, 
residual bacterial activity (which may not be halted even when samples are frozen at -18 °C [53]), or a 
combination of such events. 
 
 
Figure 5. GC×GC-TOFMS TIC contour plots of H. influenzae cultured under logarithmic growth phase 
conditions and analyzed after a) short-term and b) long-term storage. 
 
 Overall, Statistical Compare approach B generated a list of 320 aligned peaks. Of these 320 
peaks, 25 detected compounds met the previously described post-processing criteria and were 
subsequently used for PCA analysis. Discrimination was observed between the samples analyzed after 
short-term storage compared with long-term storage using PCA as shown in the scores plots in 
figure 6(a). This discrimination can be attributed to the compounds identified in the loadings plot 
(figure 6(b)) which are listed in Table S-3 in the Supplementary Data. Overall, the first principal 
component (PC-1) accounted for 33% of the variation in the dataset. Discrimination occurred along 
this axis between the short-term and long-term storage conditions. The second principal component 
(PC-2) accounted for 16% of the variation in the dataset, and discrimination between the bacteria and 
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Figure 6. Principal component analysis using pre-processed GC×GC-TOFMS peak area data for compounds 
detected in analyzed samples using Statistical Compare approach B: a) scores plot of PC-1 and PC-2 
distinguishing storage length; b) loadings plot of PC-1 and PC-2; c) scores plot of PC-2 and PC-3 distinguishing 
growth phase; d) loadings plot of PC-2 and PC-3. Compound numbers in loadings plots correspond to the list of 
compounds in Table S-3 in the Supplementary Data. Log = logarithmic growth phase and stat = stationary 
growth phase. 
 
 Variation in storage conditions can clearly impact the number of VOCs detected in bacteria 
samples and the VOC profile reported. Studies that remove cells by centrifugation prior to volatile 
analysis may reduce some of the variation described above. Storage at lower temperatures (e.g. -70 
to -80 °C) could also further reduce or inhibit bacterial activity [53,54]. Regardless, as access to 
analytical instrumentation may be limited, future work should explicitly document sample storage 
conditions in order to prevent misrepresentation of the data and to allow for datasets within the 
literature to be appropriately compared. Standardizing the storage conditions of samples may also 
increase the ability to discriminate between bacterial species using multivariate statistics. 
 
3.4. Growth Phase 
 In vitro bacterial growth can be modeled by plotting the natural logarithm of the number of 
bacteria cells vs. incubation time, resulting in a growth curve with 4 distinct phases: lag phase, 
logarithmic (or exponential) phase, stationary phase and death phase [55]. During the lag phase the 
bacteria adapt to their new environment (e.g. following inoculation into fresh growth medium) and the 
cells begin to grow. Shortly after the bacteria adjust to their new growth conditions they enter the 
logarithmic phase where they reach their maximum growth rate. Continued exponential growth begins 
to exhaust essential nutrients and the formation of metabolic waste alters the conditions of the growth 
medium producing the horizontal linear portion of the growth curve referred to as the stationary 
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 Since chronic respiratory infections are not easily eradicated from the CF lung once acquired, 
the ability to distinguish early-stage, acute infections from chronic infections may provide clinicians 
with additional information about the most appropriate treatment strategy. In this study, we compared 
logarithmic and stationary growth phases for each bacterial species as these provide clearly 
contrasting metabolic states. 
 The VOC profiles acquired of samples from stationary phase cultures were more complex 
than those samples from logarithmic phase cultures, with an average increase of approximately 40 
VOCs. When the third principal component (PC-3) was taken into consideration for the detected 
compounds obtained from Statistical Compare approach B, the logarithmic and stationary phases of 
growth could be differentiated based on their VOC profiles (figure 6(c)). Overall, PC-3 accounted for 
12% of the variation in the dataset, and discrimination between the growth phases was observed along 
this axis. This discrimination can be attributed to the compounds shown in the loadings plot 
(figure 6(d)) which are listed in Table S-3 in the Supplementary Data. In order to determine if the 
growth phases could be differentiated within an individual bacterial species, each species was 
analyzed independently by PCA using the 25 detected compounds isolated from Statistical Compare 
approach B. Using this approach, logarithmic and stationary phase metabolic profiles could be 
differentiated using PC-3 for P. aeruginosa, S. milleri and S. pneumoniae but not for B. cenocepacia, 
H. influenzae and S. maltophilia. Figure 7 demonstrates a representative PCA scores plot of PC-2 vs. 
PC-3 obtained for P. aeruginosa.  
 
 
Figure 7. Principal component analysis using pre-processed GC×GC-TOFMS peak area data for P. aeruginosa 
and LB-Lennox control samples using compounds detected with Statistical Compare approach B. Log = 
logarithmic growth phase and stat = stationary growth phase. 
 
4. Concluding Remarks 
 Previous studies considering only one or two bacterial species have claimed to identify 
species-specific biomarkers for CF-associated pathogens. The main objective of this study was to 
investigate whether six different CF-associated bacterial species could be differentiated based on their 
volatile metabolomic profiles collected and analyzed using HS-SPME-GC×GC-TOFMS. Although it 
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study has demonstrated that a large subset of the bacterial volatome (i.e. VOC profile), rather than a 
single biomarker, is required for bacterial species identification.  
 Due to similarities in the metabolic pathways of CF-associated bacteria, it is important to 
investigate the broad range of bacteria that may be detected in the CF lung in order to accurately 
recognize and differentiate their volatomes. Expanding volatile metabolomic profiling to encompass 
additional bacterial species will aid in the development of in situ tools for diagnostic purposes which 
are capable of differentiating common bacterial species that could be present in the airways as a result 
of a variety of different lung infections worldwide such as tuberculosis. This study did not aim to 
identify species-specific biomarkers; however, the approaches used herein could be applied in future 
studies (with the use of high replicate datasets) for species-specific volatome discovery, including 
other more difficult situations/organisms (e.g. influenza virus). 
 Sample storage conditions are often not noted in published studies; however, this study has 
shown that storage length can alter the VOC profile and should be considered when reporting 
bacterial volatomes (or biomarkers). Although the growth phases could not be differentiated for all of 
the bacterial species investigated, the differentiation of all six bacteria was improved under 
logarithmic growth phase conditions compared with stationary growth phase conditions. This 
knowledge may be important when considering future diagnostic tools using exhaled breath analysis 
for the early detection and identification of acute pulmonary infections. 
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